NYSEARCA:XBI SPDR S&P Biotech ETF (XBI) Price, Holdings, & News → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free XBI Stock Alerts $92.95 -1.76 (-1.86%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$92.84▼$95.2550-Day Range$87.06▼$102.9352-Week Range$63.80▼$103.52Volume11.45 million shsAverage Volume11.92 million shsMarket Capitalization$7.13 billionAssets Under Management$7.39 billionDividend YieldN/ANet Expense Ratio0.35% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get SPDR S&P Biotech ETF alerts: Email Address About SPDR S&P Biotech ETF (NYSEARCA:XBI)SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.Read More XBI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XBI ETF News HeadlinesFebruary 29, 2024 | msn.comBiotech Stocks Are on a Tear. They Could Keep Climbing.February 28, 2024 | wsj.comHeard on the Street Recap: Zooming UpMarch 18, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.February 13, 2024 | reuters.comSpdr S&P Biotech EtfFebruary 10, 2024 | investing.comXBI ETF Stock Price HistoryFebruary 3, 2024 | finance.yahoo.comSPDR S&P Biotech ETF (XBI)January 8, 2024 | msn.comHow To Buy Hot And Promising — But Uncertain — Biotech StocksJanuary 8, 2024 | benzinga.com5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway MondayMarch 18, 2024 | Behind the Markets (Ad)The only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.January 5, 2024 | reuters.comLate M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conferenceSee More Headlines Receive XBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerSSgA Fund NameSPDR S&P Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:XBI Inception Date1/31/2006 Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio Webwww.spdrs.com Phone+1-866-7872257Fund Focus Asset ClassEquity BenchmarkS&P Biotech Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings124 Fund Statistics Assets Under Management$7.39 billion Average Daily Volume$12.10 million Discount/Premium0.05% Administrator, Advisor and Custodian AdministratorSSgA Funds Management, Inc. AdvisorSSgA Funds Management, Inc. CustodianState Street Bank and Trust Company DistributorState Street Global Advisors Funds Distributors, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume77,605 Put Options44,407 Call Options33,198 Short Interest51,430,000 shs Miscellaneous Outstanding Shares76,700,000Beta0.97 Creation Unit50,000 Creation Fee$250.00 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now SPDR S&P Biotech ETF ExpensesTypeXBIHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.35%0.57%0.54%0.50%0.51%Other Expenses0.00%0.40%0.54%0.64%0.58%Total Expense0.35%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.53%-0.54%-0.68%-0.56%Net Expense0.35%0.61%0.60%0.57%0.58% SPDR S&P Biotech ETF (XBI) Holdings & ExposureTop 10 XBI HoldingsBridgeBio Pharma(NASDAQ:BBIO)Holding Weight: 2.26%Revolution Medicines(NASDAQ:RVMD)Holding Weight: 1.45%Halozyme Therapeutics(NASDAQ:HALO)Holding Weight: 1.43%ACADIA Pharmaceuticals(NASDAQ:ACAD)Holding Weight: 1.33%Catalyst Pharmaceuticals(NASDAQ:CPRX)Holding Weight: 1.31%Novavax(NASDAQ:NVAX)Holding Weight: 1.27%Neurocrine Biosciences(NASDAQ:NBIX)Holding Weight: 1.26%AbbVie(NYSE:ABBV)Holding Weight: 1.22%Incyte(NASDAQ:INCY)Holding Weight: 1.22%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 1.21%XBI Sector ExposureXBI Industry ExposureFull Holdings Details Key ExecutivesJames E. Ross (Age 52)President, Trustee Peter A. Ambrosini (Age 69)Chief Compliance Officer Michael P. Riley (Age 44)Vice President Gary L. French (Age 64)Treasurer John W. Clark (Age 46)Assistant Treasurer Matthew W. Flaherty (Age 42)Assistant Treasurer Chad C. Hallett (Age 47)Assistant Treasurer of Street tracks series trust Mary Moran Zeven (Age 52)Secretary Scott M. Zoltowski (Age 44)Assistant Secretary Dave KellyIndependent TrusteeMore ExecutivesSimilar ETFsiShares Biotechnology ETFNASDAQ:IBBiShares U.S. Medical Devices ETFNYSEARCA:IHIiShares Global Healthcare ETFNYSEARCA:IXJiShares U.S. Healthcare ETFNYSEARCA:IYHFidelity MSCI Health Care Index ETFNYSEARCA:FHLCInstitutional OwnershipKingdon Capital Management L.L.C.Sold 210,000 shares on 3/18/2024Ownership: 0.000%B. Riley Wealth Advisors Inc.Sold 933 shares on 3/15/2024Ownership: 0.008%Leo Wealth LLCBought 2,317 shares on 3/14/2024Ownership: 0.003%Trust Co. of VermontSold 1,065 shares on 3/8/2024Ownership: 0.003%ICA Group Wealth Management LLCBought 300 shares on 3/8/2024Ownership: 0.000%View All Institutional Transactions XBI ETF - Frequently Asked Questions How have XBI shares performed in 2024? SPDR S&P Biotech ETF's stock was trading at $89.29 at the start of the year. Since then, XBI stock has increased by 4.1% and is now trading at $92.95. View the best growth stocks for 2024 here. What does XBI invest in? SPDR S&P Biotech ETF is a equity fund issued by SSgA. XBI focuses on health care investments and follows the S&P Biotech Index. The fund's investments total to approximately $7.39 billion assets under management. What stocks does SPDR S&P Biotech ETF hold? XBI invests in 124 holdings. Some of the stocks in their portfolio include BridgeBio Pharma (BBIO), Revolution Medicines (RVMD), Halozyme Therapeutics (HALO), ACADIA Pharmaceuticals (ACAD), Catalyst Pharmaceuticals (CPRX), Novavax (NVAX), Neurocrine Biosciences (NBIX), AbbVie (ABBV), Incyte (INCY) and Vertex Pharmaceuticals (VRTX). What is the management fee for SPDR S&P Biotech ETF? SPDR S&P Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for XBI is 0.35%. What other stocks do shareholders of SPDR S&P Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Biotechnology ETF (IBB), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX). Who are SPDR S&P Biotech ETF's major shareholders? SPDR S&P Biotech ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Citadel Advisors LLC (0.00%), Avoro Capital Advisors LLC (5.79%), Nantahala Capital Management LLC (0.00%), Goldman Sachs Group Inc. (0.00%), Healthcare of Ontario Pension Plan Trust Fund (3.14%) and Perceptive Advisors LLC (0.00%). How do I buy shares of SPDR S&P Biotech ETF? Shares of XBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:XBI) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Gates Bets on $15 Trillion BonanzaWeiss RatingsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.